This application requests continuing support for the Cancer Research Center at the University of Chicago (UCCRC). The 157 members of the UCCRC are organized into seven established programs (Molecular Biology of Cell Growth and Differentiation; Cancer Molecular Genetics; Immunology and Cancer; Clinical and Experimental Therapeutics, Advanced Imaging, Genitourinary Oncology, and Clinical Cancer Genetics and Prevention). Clinical research is a major focus of multidisciplinary activity at the UCCRC. Over 750 individual patients (870 enrollments) were accrued in 2000 on protocols supported, in part, by NCI cooperative agreements and contracts to conduct phase 1, phase II and phase III clinical trials. The UCCRC is the host institution for the Cancer and Leukemia Group B (CALGB) and also participates in the Radiation Therapy Oncology Group, the Gynecologic Oncology Group and the Children's Oncology Group. Funds are requested in this application for Senior and Program Leaders, Planning and Evaluation, Developmental Funds, Administration, Protocol Specific Research, the Protocol Review and Monitoring System and fourteen shared resources/facilities (Transgenic Mouse/Embryonic Stem Cell; DNA Sequencing; Oligopeptide Synthesis; Immunology Applications; Electron Microscopy; Pharmacology Core; Scientific Visualization and Image Analysis; Digital Light Microscopy; Human Immunological Monitoring; Magnetic Resonance Imaging and Spectroscopy; Functional Genomics; Laser Capture Microdissection; Protocol and Data Management Office and Biostatistics and Information Technology). The overall goal of the UCCRC is to discover and translate new cancer-specific knowledge to prevent, detect and treat cancer; specifically (1) to discover and develop new biological knowledge; (2) to discover and develop new clinical treatments for cancer; (3) to discover and develop new technology useful in addressing the problem of cancer and (4) to discover and develop new approaches to prevent cancer. By stimulating and supporting collaborative interdisciplinary cancer-focused research in molecular biology, genetics, immunology and imaging, by translating both UCCRC discoveries and those of other centers to multidisciplinary clinical treatment programs for patients with cancer, and conducting genetics-based cancer screening and prevention research, the UCCRC will reduce the public health burden of cancer.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
2P30CA014599-28
Application #
6466093
Study Section
Subcommittee G - Education (NCI)
Program Officer
Shafik, Hasnaa
Project Start
1977-02-01
Project End
2007-03-31
Budget Start
2002-05-15
Budget End
2003-03-31
Support Year
28
Fiscal Year
2002
Total Cost
$3,602,038
Indirect Cost
Name
University of Chicago
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
225410919
City
Chicago
State
IL
Country
United States
Zip Code
60637
Trujillo, Jonathan A; Sweis, Randy F; Bao, Riyue et al. (2018) T Cell-Inflamed versus Non-T Cell-Inflamed Tumors: A Conceptual Framework for Cancer Immunotherapy Drug Development and Combination Therapy Selection. Cancer Immunol Res 6:990-1000
Zeng, Zongyue; Huang, Bo; Huang, Shifeng et al. (2018) The development of a sensitive fluorescent protein-based transcript reporter for high throughput screening of negative modulators of lncRNAs. Genes Dis 5:62-74
Lee, Ji-Hye; Park, Beom Seok; Han, Kang R et al. (2018) Insight Into the Interaction Between RNA Polymerase and VPg for Murine Norovirus Replication. Front Microbiol 9:1466
Cheng, Jason X; Chen, Li; Li, Yuan et al. (2018) RNA cytosine methylation and methyltransferases mediate chromatin organization and 5-azacytidine response and resistance in leukaemia. Nat Commun 9:1163
Johnson, Marianna B; Hoffmann, Joscelyn N; You, Hannah M et al. (2018) Psychosocial Stress Exposure Disrupts Mammary Gland Development. J Mammary Gland Biol Neoplasia 23:59-73
Sweis, Randy F; Zha, Yuanyuan; Pass, Lomax et al. (2018) Pseudoprogression manifesting as recurrent ascites with anti-PD-1 immunotherapy in urothelial bladder cancer. J Immunother Cancer 6:24
Kathayat, Rahul S; Cao, Yang; Elvira, Pablo D et al. (2018) Active and dynamic mitochondrial S-depalmitoylation revealed by targeted fluorescent probes. Nat Commun 9:334
Liu, Jun; Eckert, Mark A; Harada, Bryan T et al. (2018) m6A mRNA methylation regulates AKT activity to promote the proliferation and tumorigenicity of endometrial cancer. Nat Cell Biol 20:1074-1083
Bhanvadia, Raj R; VanOpstall, Calvin; Brechka, Hannah et al. (2018) MEIS1 and MEIS2 Expression and Prostate Cancer Progression: A Role For HOXB13 Binding Partners in Metastatic Disease. Clin Cancer Res 24:3668-3680
Wood, Kevin; Byron, Elizabeth; Janisch, Linda et al. (2018) Capecitabine and Celecoxib as a Promising Therapy for Thymic Neoplasms. Am J Clin Oncol 41:963-966

Showing the most recent 10 out of 668 publications